XERIS BIOPHARMA HOLDINGS INC (XERS) Stock Balance Sheet
NASDAQ:XERS • US98422E1038
Current stock price
5.515 USD
+0.07 (+1.38%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 111.04M | 71.62M | 67.45M | 122.00M | 67.30M | |||
| Marketable Securities | N/A | 0.00 | 5.00M | 0.00 | 35.20M | |||
| Receivables | 51.05M | 40.41M | 39.20M | 30.80M | 17.50M | |||
| Inventories | 68.67M | 48.17M | 38.84M | 24.70M | 18.10M | |||
| Other Current Assets | 9.55M | 7.45M | 5.78M | 9.30M | 4.60M | |||
| Total Current Assets | 240.31M | 167.66M | 156.26M | 186.80M | 142.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 27.06M | 28.21M | 29.18M | 9.50M | 6.60M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | 22.86M | 22.86M | 22.86M | 22.90M | 22.90M | |||
| Intangibles | 88.08M | 98.92M | 109.76M | 120.60M | 131.50M | |||
| Other Non-Current Assets | 5.22M | 5.41M | 4.54M | 4.70M | 800.00K | |||
| Total Non-Current Assets | 143.21M | 155.40M | 166.34M | 157.70M | 161.80M | |||
| TOTAL ASSETS | 383.53M | 323.06M | 322.60M | 344.50M | 304.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 15.10M | N/A | N/A | N/A | |||
| Accrued Expenses | 101.61M | 81.96M | 63.35M | 66.40M | 68.10M | |||
| Accounts Payable | 3.08M | 2.29M | 11.56M | 4.60M | 8.90M | |||
| Other Current Liabilities | 4.89M | 1.09M | 20.28M | 2.70M | 2.00M | |||
| Total Current Liabilities | 109.57M | 100.44M | 95.19M | 73.60M | 79.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 220.34M | 217.01M | 190.93M | 187.10M | 88.10M | |||
| Deferred Taxes/Income | N/A | 0.00 | 2.27M | 3.50M | 4.90M | |||
| Other Non-Current Liabilities | 39.93M | 35.23M | 40.99M | 35.10M | 37.10M | |||
| Total Non-Current Liabilities | 260.26M | 252.23M | 234.19M | 225.70M | 130.10M | |||
| TOTAL LIABILITIES | 369.84M | 352.68M | 329.38M | 299.30M | 209.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -671.31M | -671.86M | -617.02M | -554.80M | -460.10M | |||
| Additional Paid In Capital | 685.00M | 642.26M | 610.25M | 600.00M | 555.40M | |||
| Common Shares | 17.00K | 15.00K | 14.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -25.00K | -25.00K | -25.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 166.22M | 149.43M | 138.13M | 136.30M | 124.90M | |||
| Tangible Book Value per Share | -0.59 | -1.01 | -1.01 | -0.72 | -0.47 | |||
| Total Shareholders' Equity | 13.69M | -29.61M | -6.78M | 45.20M | 95.20M | |||
| TOTAL LIABILITIES AND EQUITY | 383.53M | 323.06M | 322.60M | 344.50M | 304.40M | |||
| Statistics | ||||||||
| Debt/Equity | 16.10 | -7.33 | -28.15 | 4.14 | 0.93 | |||
| Current Ratio | 2.19 | 1.67 | 1.64 | 2.54 | 1.81 | |||
| Return On Assets (ROA) | 0.14% | -16.97% | -19.30% | -27.49% | -40.31% | |||
| Return On Equity (ROE) | 4.05% | N/A | N/A | -209.51% | -128.89% | |||
| Return On Invested Capital (ROIC) | 7.18% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 12.07% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 37.84% | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21